An Observational Descriptive Assessment of Lipid Profile of Diabetic Patients
Authors/Creators
- 1. Associate Professor, Department of General Medicine, Shri Ramkrishna Institute of Medical Sciences and Sanaka Hospital, Durgapur, West Bengal, India
- 2. Assistant Professor, Department of General Medicine, ICARE Institute of Medical Sciences and Research and Dr. Bidhan Chandra Roy Hospital, Haldia
Description
Aim: The aim of this study was the assessment of lipid profiles mainly triglycerides in diabetic patients from Bihar region. Methods: This was a cross-sectional study was done in the Department of General medicine, Shri Ramkrishna Institute of Medical Sciences and Sanaka Hospital, Durgapur, West Bengal, India, for the period of 1 year. A total of 160 newly diagnosed type 2 diabetes mellitus within the last 3 months using the ADA (American Diabetes Association) criteria and both males and females were include in this study for determine the lipid profile levels. Results: According to ATP III classification 68 (42.5%) participants had normal serum triglycerides levels which is <150 mg/dl whereas 112 (57.5%) participants had an abnormal level of serum triglycerides. Among the 112 (57.5) participants with abnormal triglycerides, 32.5% had borderline high levels (150-199mg/dl), 25% had high levels (200-499 mg/dl). In our study, 52.5% participants had low HDL and 47.5% participants had normal HDL. The Gender distribution showed that 32 male participants and 52 female participants had low HDL. In our study, among the 160 participants, 110 (68.75%) participants had desirable total Cholesterol levels of <200mg/dl, 40 (25%) had borderline high levels of 200- 239mg/dl and 10 (6.25%) had high total cholesterol levels of ≥240mg/dl. 20 (12.5%) had high levels of LDL of which 6 were males and 14 were females. 4 (2.5%) participants had very high levels of LDL of which 2 was male and 2 was female. Conclusions: Patients who have diabetes mellitus are at a greater risk of developing early atherosclerosis and microvascular problems if they have hyperlipidemia, which is the most prevalent diabetic consequence. The development and progression of typical lipid abnormalities in diabetes, such as elevated triglycerides, LDL, serum cholesterol, and low HDL, may be prevented by maintaining good control of blood glucose levels.
Abstract (English)
Aim: The aim of this study was the assessment of lipid profiles mainly triglycerides in diabetic patients from Bihar region. Methods: This was a cross-sectional study was done in the Department of General medicine, Shri Ramkrishna Institute of Medical Sciences and Sanaka Hospital, Durgapur, West Bengal, India, for the period of 1 year. A total of 160 newly diagnosed type 2 diabetes mellitus within the last 3 months using the ADA (American Diabetes Association) criteria and both males and females were include in this study for determine the lipid profile levels. Results: According to ATP III classification 68 (42.5%) participants had normal serum triglycerides levels which is <150 mg/dl whereas 112 (57.5%) participants had an abnormal level of serum triglycerides. Among the 112 (57.5) participants with abnormal triglycerides, 32.5% had borderline high levels (150-199mg/dl), 25% had high levels (200-499 mg/dl). In our study, 52.5% participants had low HDL and 47.5% participants had normal HDL. The Gender distribution showed that 32 male participants and 52 female participants had low HDL. In our study, among the 160 participants, 110 (68.75%) participants had desirable total Cholesterol levels of <200mg/dl, 40 (25%) had borderline high levels of 200- 239mg/dl and 10 (6.25%) had high total cholesterol levels of ≥240mg/dl. 20 (12.5%) had high levels of LDL of which 6 were males and 14 were females. 4 (2.5%) participants had very high levels of LDL of which 2 was male and 2 was female. Conclusions: Patients who have diabetes mellitus are at a greater risk of developing early atherosclerosis and microvascular problems if they have hyperlipidemia, which is the most prevalent diabetic consequence. The development and progression of typical lipid abnormalities in diabetes, such as elevated triglycerides, LDL, serum cholesterol, and low HDL, may be prevented by maintaining good control of blood glucose levels.
Files
IJTPR,Vol12,Issue5,Article15.pdf
Files
(191.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:e02aafdc8d70cc3e38aa6e04761d5f86
|
191.1 kB | Preview Download |
Additional details
Dates
- Accepted
-
2022-04-12
Software
References
- 1. Samatha P, Venkateswarlu M, Siva Prabodh V. Lipid Profile Levels in Type 2 Diabetes Mellitus from the Tribal Population of Adilabad in Andhra Pradesh, India. Journal of Clinical and Diagnostic Research. 2012 May (Suppl2),6(4): 590-592. 2. Ebrahim S, Kinra S, Bowen L, Andersen E, BenShlomo Y. The effect of the rural to urban migration on obesity and diabetes in India: A cross-sectional study. PLos Med 7(4):e1000268.doi:10.1371/journal.pmed. 1000268. 3. Mohan V, Deepa M, Deepa R, Shanthirani CS, Farooq S. Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban south India – The Chennai urban rural epidemiology study (CURES-17). Diabetalogia 2006; 49:1175-78. 4. Mahato RV, Gyawali P, Raut PP, Regmi P, Kelanand PS, Dipendra RP, et al. Association between glycaemic control and serum lipid profile in type 2 diabetic patients: glycated haemoglobin as a dual biomarker. Biomed Res. 2011;22(3):375- 80. 5. Taskinen MR. Diabetic dyslipidemia. Atheroscler Suppl. 2002;3(1):47-51. 6. Ronald M. Krauss. Lipids and Lipoproteins in Patients with Type 2 Diabetes. Diabetes Care Jun 2004;22(6)1496-504. 7. Hokanson JE, Austin MA: Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta- analysis of population-based prospective studies. J Cardiovasc. Risk. 1996;3(2):213-9. 8. Keating GM, Croom KF, Fenofibrate: a review of its use in primary dyslipidemia, the metabolic syndrome and type 2 diabetes mellitus. Drugs. 2007,67(1):121- 53. 9. Deepa M, Farooq S, Datta M, Deepa R, Mohan V. Prevalence of metabolic syndrome using WHO, ATPIII and IDF definitions in Asian Indians: The Chennai Urban Rural Epidemiology Study. Diabetes Metab Res Rev. 2007;23(2):127- 34. 10. Nahar S, Rahman MZ, Ullah M, Debnath BC, Sultana N, Farhad CMRQ. Prevalence of Metabolic Syndrome in Newly diagnosed Type 2 Diabetes Mellitus. Cardiovase J. 2011;4(1):17-25. 11. Bharadwaj S, Misra A, Misra R, Goel K, Bhatt SP, Rastogi K et al. High Prevalence of abdominal, intraabdominal and subcutaneous adiposity and clustering of risk factors among urban asian Indians in north India. PLos One. 2011;6(9):e24362 12. Celikhisar, H., & Ilkhan, G. D. Determining The Etiological Factors in Pleural Fluid by Crp, Albumin And Procalcitonin Levels: New markers in pleural fluid identification. Journal of Medical Research and Health Sciences, 2020:3(2), 880–885. 13. Joshi SR, Anjana RM, Deepa M, Pradeepa R, Bhansali A, DHandania VK. Prevalence of dyslipidemia in urban and rural India. The ICMR- INDIAB Study. PLoS ONE. 2014;9(5):e96808. 14. Karadag MK, Akbulut M. Low HDL levels as the most common metabolic syndrome risk factor in heart failure. Int Heart J. 2009 Sep;50(5):571-80. 15. Ogbera AO. Prevalence and gender distribution of the metabolic syndrome. Diabetol Metab Syndr. 2010; 2(1): 1.